Caladrius Biosciences, Inc. (CLBS): Price and Financial Metrics
CLBS Price/Volume Stats
| Current price | $6.40 | 52-week high | $9.75 |
| Prev. close | $0.51 | 52-week low | $0.38 |
| Day low | $5.73 | Volume | 1,796,440 |
| Day high | $9.75 | Avg. volume | 522,308 |
| 50-day MA | $0.52 | Dividend yield | N/A |
| 200-day MA | $0.65 | Market Cap | 387.49M |
CLBS Stock Price Chart Interactive Chart >
Caladrius Biosciences, Inc. (CLBS) Company Bio
Caladrius Biosciences, Inc., formerly NeoStem, Inc., through its subsidiary, PCT, LLC, a Caladrius Company (PCT), provides development and manufacturing services to the cell therapy industry (which includes cell-based gene therapy). PCT specializes in cell and cell-based gene therapies.
CLBS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -53.62% |
| 5-year | -80.87% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -41.15% |
| 2020 | -43.03% |
| 2019 | -29.49% |
Loading social stream, please wait...